Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC).
暂无分享,去创建一个
A. Schneeweiss | S. Loibl | V. Nekljudova | G. von Minckwitz | S. Glück | Xiaolong Luo | R. Crane | Huiling Li